CD24 and carcinoma: In Egypt, a completed observational trial (NCT04907422) employed CD24-AuNC as a diagnostic marker for Carcinoma Ex Pleomorphic Adenoma of Salivary Glands, proposing CD24-AuNC as a sensitive and specific diagnostic tool (271).